Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
2,080.00    -62.00 (-2.89%)
Bid:
2,066.00
Ask:
2,070.00
Spread: 4.00 (0.194%)
Market Cap: £3.48b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Directorate Changes

26 Jul 2017 10:02

RNS Number : 1398M
Johnson Matthey PLC
26 July 2017
 

Johnson Matthey Plc Directorate Changes

 

The board of Johnson Matthey Plc is pleased to announce the appointment of John O'Higgins, as a non-executive director of the company. He will join the board with effect from 16th November 2017.

 

John is currently Chief Executive of Spectris plc, a leading supplier of productivity-enhancing instrumentation and controls. He joined the board of Spectris plc as Chief Executive in January 2006. Prior to this John worked for Honeywell in a number of management roles, including as president of automation and control solutions, Asia Pacific. He began his career as a design engineer at Daimler-Benz in Stuttgart.

 

John will be replacing Colin Matthews CBE FREng, a non-executive director and Chairman of the Remuneration Committee. Colin is standing down from his role with effect from 15th November 2017 after five years on the board, having been appointed a non-executive director in October 2012 and Chairman of the Remuneration Committee in July 2016.

 

Chris Mottershead, a non-executive director, will be appointed as Chairman of the Remuneration Committee from 16th November 2017.

 

Tim Stevenson OBE, Chairman, commented:

 

"On behalf of all of us on the board I would like to thank Colin for his significant contributions during his time as a non-executive director.

 

I am very pleased to welcome John to the board and we look forward to working with him and benefiting from his extensive business and industrial experience".

 

 

Disclosures required pursuant to Rule 9.6.13 of the Listing Rules of the Financial Conduct Authority (including directorships held in other publicly quoted companies at any time in the previous five years)

 

John was appointed as a director of Spectris plc in January 2006, a company listed on the London Stock Exchange.

 

From September 2010 to April 2015, John was a non-executive director of Exide Technologies, Inc, a company listed on the Nasdaq stock exchange.

 

Other than as stated in this announcement, there are no other disclosures required pursuant to Rule 9.6.13 of the Listing Rules of the Financial Conduct Authority.

 

Enquiries:

Sally Jones

Director of Corporate Communications

020 7269 8407

Andrew Grant/David Allchurch

Tulchan Communications

020 7353 4200

www.matthey.com

26th July 2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPGUGUMUPMUBQ
Date   Source Headline
3rd Aug 20173:49 pmRNSDirector/PDMR Shareholding
3rd Aug 20173:46 pmRNSDirector/PDMR Shareholding
3rd Aug 20173:41 pmRNSDirector/PDMR Shareholding
3rd Aug 20173:37 pmRNSDirector/PDMR Shareholding
3rd Aug 20173:30 pmRNSDirector/PDMR Shareholding
3rd Aug 20173:20 pmRNSDirector/PDMR Shareholding
3rd Aug 20173:16 pmRNSDirector/PDMR Shareholding
1st Aug 201711:33 amRNSDirector/PDMR Shareholding
31st Jul 20174:21 pmRNSDirector/PDMR Shareholding
28th Jul 20172:42 pmRNSResult of AGM
28th Jul 20177:00 amRNSAGM Statement
26th Jul 201710:02 amRNSDirectorate Changes
21st Jul 201711:02 amRNSDirector/PDMR Shareholding
22nd Jun 20172:58 pmRNSDirector/PDMR Shareholding
20th Jun 201711:43 amRNSAnnual Financial Report
1st Jun 20174:19 pmRNSDirectorate Change
1st Jun 20177:00 amRNSFinal Results
19th May 20175:00 pmRNSHolding(s) in Company
18th May 20175:24 pmRNSDirector/PDMR Shareholding
18th May 20175:16 pmRNSDirector/PDMR Shareholding
3rd May 201711:04 amRNSDirector/PDMR Shareholding
27th Apr 20174:40 pmRNSHolding(s) in Company
21st Apr 20171:54 pmRNSDirector/PDMR Shareholding
20th Apr 20174:00 pmRNSOrganisation Changes
27th Mar 20175:56 pmRNSHolding(s) in Company
16th Mar 20172:28 pmRNSDirector/PDMR Shareholding
20th Feb 20174:04 pmRNSDirector/PDMR Shareholding
16th Feb 20173:14 pmRNSDirector/PDMR Shareholding
10th Feb 20172:54 pmRNSDirector/PDMR Shareholding
10th Feb 20171:19 pmRNSDirector/PDMR Shareholding
10th Feb 20171:12 pmRNSDirector/PDMR Shareholding
10th Feb 20171:07 pmRNSDirector/PDMR Shareholding
6th Feb 20172:55 pmRNSDirector/PDMR Shareholding
2nd Feb 20177:00 amRNSTrading Statement
19th Jan 20173:09 pmRNSDirector/PDMR Shareholding
22nd Dec 201612:21 pmRNSDirector/PDMR Shareholding
16th Dec 201611:39 amPRNHolding(s) in Company
9th Dec 20169:56 amRNSDirector/PDMR Shareholding
1st Dec 20161:39 pmPRNBlocklisting - Interim Review
25th Nov 20168:59 amRNSDirector/PDMR Shareholding
18th Nov 201610:14 amRNSDirector/PDMR Shareholding
17th Nov 20167:00 amRNSHalf-year Report
20th Oct 20161:45 pmRNSDirector/PDMR Shareholding
23rd Sep 20169:14 amRNSDirector/PDMR Shareholding
22nd Sep 201611:45 amPRNHolding(s) in Company
18th Aug 20163:49 pmRNSDirector/PDMR Shareholding
16th Aug 20163:44 pmRNSDirector/PDMR Shareholding
16th Aug 20163:41 pmRNSDirector/PDMR Shareholding
16th Aug 20163:36 pmRNSDirector/PDMR Shareholding
5th Aug 201610:35 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.